Literature DB >> 14605177

Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis.

John C Ridderhof1, Laurina O Williams, Sue Legois, Peter A Shult, Beverly Metchock, Louise N Kubista, James H Handsfield, Ronald J Fehd, Pamela H Robinson.   

Abstract

During implementation of the Centers for Disease Control and Prevention's Mycobacterium tuberculosis nucleic acid amplification (NAA) evaluation program, 27.1% of participants used the same biological safety cabinet for NAA and specimen processing; 28.8% reported not using unidirectional workflow. An association between false positives and adverse responses to quality assurance questions (P = 0.04) illustrated the need for following NCCLS recommendations.

Entities:  

Mesh：

Year:  2003        PMID： 14605177      PMCID： PMC262533          DOI： 10.1128/JCM.41.11.5258-5261.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Prospective clinical evaluation of Amplicor Mycobacterium tuberculosis PCR test as a screening method in a low-prevalence population.

Authors:  R Cartuyvels; C De Ridder; S Jonckheere; L Verbist; J Van Eldere
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

2.  Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates.

Authors:  J S Bergmann; G Yuoh; G Fish; G L Woods
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories.

Authors:  G T Noordhoek; J D van Embden; A H Kolk
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories.

Authors:  G T Noordhoek; A H Kolk; G Bjune; D Catty; J W Dale; P E Fine; P Godfrey-Faussett; S N Cho; T Shinnick; S B Svenson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

5.  Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteria.

Authors:  S Ichiyama; Y Iinuma; Y Tawada; S Yamori; Y Hasegawa; K Shimokata; N Nakashima
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Update: Nucleic acid amplification tests for tuberculosis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-07-07       Impact factor: 17.586

7.  Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens.

Authors:  G E Pfyffer; P Kissling; E M Jahn; H M Welscher; M Salfinger; R Weber
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA.

Authors:  V Jonas; M J Alden; J I Curry; K Kamisango; C A Knott; R Lankford; J M Wolfe; D F Moore
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens.

Authors:  N Miller; S G Hernandez; T J Cleary
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.

Authors:  J E Clarridge; R M Shawar; T M Shinnick; B B Plikaytis
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948
View more
  1 in total

1.  Roles of laboratories and laboratory systems in effective tuberculosis programmes.

Authors:  John C Ridderhof; Armand van Deun; Kai Man Kam; P R Narayanan; Mohamed Abdul Aziz
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.